Zymo Research’s Quick-DNA/RNA™ Viral MagBead Kit has been cleared for distribution to the European Union (EU) common market. The kit is designed for high-throughput purification of viral DNA and/or RNA from biological samples that are stored in Zymo Research’s DNA/RNA Shield.
Zymo Research recently announced that its Quick-DNA/RNA Viral MagBead Kit was cleared for distribution to the European Union (EU) common market. The product is designed for high-throughput purification of viral DNA and/or RNA from biological samples that are stored in Zymo Research’s DNA/RNA Shield. DNA/RNA Shield is used for sample collection, nucleic acid preservation, and inactivation of pathogens. The isolated high-quality nucleic acids are ready for all downstream applications such as Next-Gen Sequencing and RT-qPCR detection.
“Zymo Research has played a significant role in combating the current COVID-19 pandemic,” said Dr. Stanislav Forman, a scientist at Zymo Research. “All products in our COVID-19 testing workflow are now CE IVD marked; thus, helping our clinical customers in the EU and beyond.”
The CE IVD marked Quick-DNA/RNA Viral MagBead Kit meets EU safety, health, and environmental requirements. It can be used for the purification of viral DNA/RNA, such as SARS-CoV-2, the virus that causes COVID-19, or other pathogenic sample types. The kit is a part of several FDA EUA SARS-CoV-2 test workflows developed by prominent companies such as Illumina and Fulgent Genetics.